
Please try another search
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Stefan Scheding | 63 | 2012 | Founder & Independent Director |
Thomas Laurell | 64 | 2011 | Founder & Independent Director |
Martin Olin Andersen | 56 | 2021 | Independent Chairman of the Board |
Katherine Flagg | 63 | 2021 | Independent Board Member |
Stefan Blomsterberg | 61 | 2025 | Director |
Per Sundkvist | 59 | 2025 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review